[ad_1]
AstraZeneca makes noise daily News of an individual case and did not give details of the side effects experienced by the test person, only of “a potentially unexplained illness”. the New York Times citing an informed person, he reported that the health problem was transverse myelitis, an inflammation that hits the spinal cord and can be triggered by viral infections.
AstraZeneca’s active ingredient AZD1222 is based on the weakened version of a chimpanzee cold virus and is supposed to activate the immune system so that it can neutralize SARS-CoV-2 in the event of an infection.
Testing in various countries
In August, the pharmaceutical giant began recruiting 30,000 test subjects in the US for its largest study on the candidate vaccine. The vaccine produced by the University of Oxford is also being tested in thousands of people in Britain, and there are smaller studies in Brazil and South Africa.
Final large-scale testing phases are also underway for two other candidate vaccines: one is manufactured by Moderna Inc., the other by Mainz-based biopharmaceutical company Biontech and its US partner Pfizer. These two vaccine hopefuls work differently than the AstraZeneca drug.
